p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancerSilvana Mourón, Miguel Quintela-Fandiño, Sandra Rodríguez et al.|JNCI Cancer Spectrum|2023Cited by 2
Abstract P5-02-28: p27Kip1 V109G single-nucleotide polymorphism (SNP): pinpointing the hormone-receptor positive breast cancer subpopulation that requires CDK4/6 inhibitors in addition to endocrine therapyMiguel Quintela-Fandiño, Marcos Malumbres, Silvana Mourón et al.|Cancer Research|2023Cited by 0